RegIntel

RegIntel™ for Consulting Firms offers a comprehensive platform for accessing global regulations and guidance across the pharmaceutical, medical device, and biologics sectors. It accelerates global research by providing instant access to regulatory information from the USA, EU, and other regions.

The platform features AI-enhanced analysis capabilities, allowing users to summarize complex documents, create impact assessments, generate FAQs, and identify key actions automatically. This ensures that consultants can provide precise and efficient advice to their clients.

With customizable assistants, RegIntel™ empowers users to automate information flows and decision support, enhancing the success of their customers. The platform also offers client-customized insights, enabling the storage and analysis of client-specific documents to generate strategic recommendations tailored to specific market goals.

RegIntel™ integrates over 100 million data points into a single platform, covering approvals, clinical trials, adverse events, and safety reports. This vast dataset supports consultants in delivering confident, data-backed advice to their clients.

According to Tatyana G., Vice-president of Regulatory Affairs, Lexim AI has significantly contributed to her medical-device company's understanding of AI applications in regulatory affairs.